首页 | 官方网站   微博 | 高级检索  
     

头孢哌酮/舒巴坦钠静脉滴注致过敏性休克死亡
引用本文:高玲,杨晓庆.头孢哌酮/舒巴坦钠静脉滴注致过敏性休克死亡[J].药物不良反应杂志,2008,10(6):445-446.
作者姓名:高玲  杨晓庆
作者单位:新疆石河子人民医院药剂科,新疆,石河子,832000
摘    要:1例48岁女性患者,因患支气管炎给予头孢哌酮/舒巴坦钠3g溶于0.9%氯化钠注射液250ml静脉滴注。静脉滴注约10min时,患者出现呼吸困难,烦躁不安,口唇发绀,意识丧失,血压未测及。立即停药,给予吸氧、肾上腺素、地塞米松及氢化可的松治疗,最终抢救无效死亡。

关 键 词:头孢哌酮/舒巴坦钠  过敏性休克  死亡  不良反应

Death from anaphylactic shock induced by an IV infusion of cefoperazone/sulbactam
Gao Ling,Yang Xiaoqing.Death from anaphylactic shock induced by an IV infusion of cefoperazone/sulbactam[J].Adverse Drug Reactions Journal,2008,10(6):445-446.
Authors:Gao Ling  Yang Xiaoqing
Affiliation:(Department of Pharmacy, Shihezi People's Hospital of Xinjiang, Shihezi 832000, Xinjiang Uygur Autonomous Region, China)
Abstract:A 48-year-old woman was given an IV infusion of cefoperazone/sulbactam 3 g dissolved in 0.9% sodium chloride injection 250 ml for treatment of bronchitis. The patient developed difficulty breathing, agitation, lips cyanosis, and unconsciousness with an unrecordable BP about 10 minutes after starting the infusion. Cefoperazone/sulbactam was discontinued immediately. Despite treatment with oxygen inhalation, adrenaline, dexamethasone, and hydroeortisone, she died.
Keywords:cefoperazone/sulbactam  anaphylactic shock  death  adverse reaction
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号